Your session is about to expire
← Back to Search
Structured Exercises for Prostate Cancer
N/A
Recruiting
Led By Shehzad Basaria, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Planned ADT for at least 6 months
Hormone-naive men about to undergo medical or surgical ADT
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will study if structured exercises can help preserve physical function in men with prostate cancer undergoing ADT.
Who is the study for?
Men over 60 with active prostate cancer starting hormone therapy for at least 6 months can join. They must be able to consent and expected to live more than 6 months. Those with conditions that limit exercise, recent fractures, joint replacements, or serious heart disease cannot participate.Check my eligibility
What is being tested?
The study tests if exercises like resistance training and flexibility/balance workouts can maintain muscle mass, strength, and physical function in men on hormone therapy for prostate cancer compared to a control group not doing these exercises.See study design
What are the potential side effects?
While the trial itself doesn't involve drugs that cause side effects, exercising may lead to muscle soreness or injury especially if not done correctly. Participants will be monitored for any exercise-related issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for hormone therapy for at least 6 months.
Select...
I am a man about to start hormone therapy for the first time.
Select...
I am a man over 60 with active prostate cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Loaded stair climb power
Secondary outcome measures
Body composition
Fatigue
Muscle strength and power
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Progressive Resistance Training ExerciseExperimental Treatment1 Intervention
Men with prostate cancer who are about to begin androgen-deprivation therapy (ADT) will attend structured progressive resistance exercise training sessions 2 times/week for six months.
Group II: Flexibility and Balance ExerciseActive Control1 Intervention
Men with prostate cancer who are about to begin androgen-deprivation therapy (ADT) will attend flexibility and balance exercises training sessions 2 times/week for six months.
Find a Location
Who is running the clinical trial?
Dana-Farber Cancer InstituteLead Sponsor
1,079 Previous Clinical Trials
340,940 Total Patients Enrolled
76 Trials studying Prostate Cancer
16,065 Patients Enrolled for Prostate Cancer
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,885 Total Patients Enrolled
1 Trials studying Prostate Cancer
142 Patients Enrolled for Prostate Cancer
Shehzad Basaria, MDPrincipal Investigator - Brigham and Women's Hospital
Boston Children's Hospital, Dana-Farber Cancer Institute
Aga Khan Medical College (Medical School)
Johns Hopkins University School Medicine (Residency)
3 Previous Clinical Trials
443 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have severe joint, muscle, blood vessel, or nerve conditions that prevent me from exercising.I am scheduled for hormone therapy for at least 6 months.I do not have severe heart problems or stroke-related weakness.I am a man about to start hormone therapy for the first time.I have had a leg or foot fracture in the last 6 months.I am a man over 60 with active prostate cancer.I have had a hip or knee replacement.You are expected to live for at least 6 months after joining the study.
Research Study Groups:
This trial has the following groups:- Group 1: Progressive Resistance Training Exercise
- Group 2: Flexibility and Balance Exercise
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the enrollment capacity for this clinical trial?
"Affirmative. Clinicaltrials.gov attests that this medical trial is enrolling participants, with the initial posting being on December 1st 2020 and most recent update occurring November 28th 2022. This research requires 40 people to be recruited from 2 distinct locations."
Answered by AI
Are there any openings left in this medical experiment for participants?
"Affirmative, the information on clinicaltrials.gov indicates that this medical trial is actively seeking patient enrolment. This study was first published on December 1st 2020 and most recently updated on November 28th 2022; it requires 40 people to participate across two sites."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger